Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for bs compounds (compound)
Most Correlated Studies
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Most Relevant Literature
- Toxicological, toxicokinetic and gastroprotective evaluation of the benzaldehyde semicarbazone.
- Pre-clinical pharmacokinetics evaluation of an anticonvulsant candidate benzaldehyde semicarbazone f…
- Influence of susceptibility to hydrolysis and hydrophobicity of arylsemicarbazones on their anti-noc…
- Antinociceptive, antiedematogenic and antiangiogenic effects of benzaldehyde semicarbazone.
- E)-4-(Benz-yloxy)benzaldehyde thio-semicarbazone.
Most Relevant Clinical Trials
- Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects
- Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease
- Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arth…
- Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment …
- Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis
